Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul 31:5:65.
doi: 10.1186/1475-2875-5-65.

From chloroquine to artemisinin-based combination therapy: the Sudanese experience

Affiliations

From chloroquine to artemisinin-based combination therapy: the Sudanese experience

E M Malik et al. Malar J. .

Abstract

Background: In Sudan, chloroquine (CQ) remains the most frequently used drug for falciparum malaria for more than 40 years. The change to artemisinin-based combination therapy (ACT) was initiated in 2004 using the co-blister of artesunate + sulfadoxine/pyrimethamine (AS+SP) and artemether + lumefantrine (ART+LUM), as first- and second-line, respectively. This article describes the evidence-base, the process for policy change and it reflects the experience of one year implementation. Relevant published and unpublished documents were reviewed. Data and information obtained were compiled into a structured format.

Case description: Sudan has used evidence to update its malaria treatment to ACTs. The country moved without interim period and proceeded with country-wide implementation instead of a phased introduction of the new policy. The involvement of care providers and key stakeholders in a form of a technical advisory committee is considered the key issue in the process. Development and distribution of guidelines, training of care providers, communication to the public and provision of drugs were given great consideration. To ensure presence of high quality drugs, a system for post-marketing drugs surveillance was established. Currently, ACTs are chargeable and chiefly available in urban areas. With the input from the Global Fund to fight AIDs, Tuberculosis and Malaria, AS+SP is now available free of charge in 10 states.

Conclusion: Implementation of the new policy is affected by the limited availability of the drugs, their high cost and limited pre-qualified manufacturers. Substantial funding needs to be mobilized by all partners to increase patients' access for this life-saving intervention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Treatment options against malaria in Sudan" conference conclusions and recommendations.
Figure 2
Figure 2
Key activities in the processing of changing from CQ to ACTs.
Figure 3
Figure 3
Phasing out of CQ as response to increasing use of ACTs over 2 years (hypothetical figures). formula image

Similar articles

Cited by

References

    1. Malik EM, Saeed OK. Malaria in Sudan: past, present and the future. Gazera Journal of Health Sciences. 2004;1:47–53.
    1. Himeidan Yel-S, Dukeen MY, El-Rayah el-A, Adam I. Anopheles arabiensis: abundance and insecticide resistance in an irrigated area of eastern Sudan. East Mediterr Health J. 2004;10:167–174. - PubMed
    1. Abdel-Hameed AA. Antimalarial drug resistance in the Eastern Mediterranean Region. East Mediterr Health J. 2003;9:492–508. - PubMed
    1. Malik EM, Nour SM, Hamid IK, Elmardi KA, Mohamed TA, Ahmed ES. From home to hospital: Beliefs and practices related to severe malaria in Sudan. Journal of Family & Community Medicine. 2005;12:85–90. - PMC - PubMed
    1. Yousif MA, Adeel AA. Antimalarials prescribing pattern in Gazera State: precepts and practices. East Mediterr Healh J. 2000;6:939–947. - PubMed

MeSH terms